Blue Water Life Science Advisors, LP Maxcyte, Inc. Transaction History

Blue Water Life Science Advisors, LP

  • $114 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$3.94 - $5.38 $5.05 Million - $6.89 Million
-1,281,063 Reduced 67.96%
603,937 $2.53 Million
Q2 2023

Aug 14, 2023
SELL
$3.69 - $5.35 $4.94 Million - $7.17 Million
-1,340,000 Reduced 41.55%
1,885,000 $8.65 Million
Q3 2022

Nov 14, 2022
BUY
$4.52 - $6.51 $14.6 Million - $21 Million
3,225,000 New
3,225,000 $21 Million

Others Institutions Holding MXCT

# of Institutions
124
Shares Held
65.6M
Call Options Held
1K
Put Options Held
2K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $426M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Blue Water Life Science Advisors, LP Portfolio

Follow Blue Water Life Science Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Water Life Science Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Water Life Science Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email